Navigation Links
Winner Medical Reports First Quarter Fiscal 2011 Results

SHENZHEN, China, Feb. 10, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN; "Winner Medical"), a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, today reported consolidated financial results for the first quarter ended December 31, 2010.

Fiscal First Quarter 2011 Results (in millions of USD, except per share data)Q1 FY2011

Q4 FY2010

% Change

Q1 FY2010

% ChangeNet Sales





13.2%Cost of Sales





19.0%Gross Profit





0.5%Gross Margin





(11.2)%Net Income Attributable to Winner Medical Group Inc.





(15.1)%EPS (Diluted)





(17.6)%Mr. Jianquan Li, Chairman and Chief Executive Officer of Winner Medical, commented, "During the first quarter of fiscal year 2011, cotton prices continued to increase and these raw material price increases were shifted to our customers. Early in the quarter, some customers chose to delay purchases and reduced their inventory while monitoring cotton price trends. Starting in November, having depleted the majority of their inventory, our customers increased their purchases again, resulting in December sales being one of the strongest months that Winner Medical has recorded in recent years. I believe the medical dressings and medical disposables markets have now largely accepted the cotton price increases from last year and we expect positive margin and sales growth for the remainder of 2011."  

First Quarter 2011 Unaudited Financial Results Winner Medical reported net sales of p>(53,846)Equity in earnings of 50 percent or less owned entities 81,285

(30,322)Income before income taxes 3,714,483

4,457,915Income taxes(373,686)

(581,887)Net income3,340,797

3,876,028Net loss attributable to non-controlling interests(12,553)

44,684Net income attributable to

Winner Medical Group Inc.3,328,244

3,920,712Comprehensive income:Net income3,340,797

3,876,028Foreign currency translation difference1,254,669

(172,924)Comprehensive income attributable to

non-controlling interests(12,988)

44,735Comprehensive income attributable to

Winner Medical Group Inc.4,582,478

3,747,839Net income attributable to Winner Medical Group Inc. per share - basic 0.14

0.18- diluted0.14

0.17Weighted average common stock outstanding- basic 24,116,281

22,363,675- diluted24,498,551

22,473,167Winner Medical Group Inc.Consolidated Balance SheetsDecember 31,September 30,20102010(Unaudited)(Unaudited)US$US$ASSETSCurrent assets:Cash and cash equivalents10,896,741

14,818,179Restricted bank deposits102,738

285,119Restricted broker margin account 2,837,655

-Held-to-maturity investments1,518,770

1,497,607Accounts receivable, less allowances for doubtful accounts of US$194,240 and US$230,200 at December 31, 2010 and September 30, 2010, respectively19,171,843

15,672,446Amounts due from affiliated companies2,529


15,945,101Prepaid expenses and other receivables10,640,347

6,929,066Income taxes recoverable-

33,974Deferred tax assets393,421

428,741Total current assets67,448,111

55,611,232Property, plant and equipment, net60,934,103

60,110,367Investment in equity investees2,241,068

2,159,784Intangible assets, net121,760

125,079Prepaid expenses and other receivables1,373,149

637,748Deferred tax assets523,735

331,785Total assets132,641,926

118,975,995LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Short-term bank loans6,009,912

-Accounts payable7,219,825

5,362,155Accrued payroll and employee benefits2,807,179

2,393,700Customer deposits881,656

687,275Accrued and other liabilities3,142,479

3,057,445Amounts due to affiliated companies50,153

58,338Income taxes payable1,713,575

1,477,212Total current liabilities21,824,779

13,036,125Deferred tax liabilities43,204

42,699Total liabilities21,867,983

13,078,824Commitments and contingencies-

-Stockholders' equity:Common stock, par value $0.001 per share; authorized 247,500,000, issued and outstanding December 31, 2010  -24,130,247 shares; September 30, 2010 - 23,950,740 shares24,131

23,951Additional paid-in capital40,435,620

40,154,494Retained earnings52,058,278

48,730,034Statutory reserves4,585,731

4,585,731Accumulated other comprehensive income 13,556,996

12,302,762Total Winner Medical Group Inc stockholders' equity110,660,756

105,796,972Non-controlling interests 113,187

100,199Total equity110,773,943


 Total liabilities and equity132,641,926

118,975,995Winner Medical Group Inc. Non-GAAP ReconciliationDecember 31,20102009US$US$Net income attributable to Winner Medical Group Inc. (GAAP)3,328,244

3,920,711Share-based compensation 281,306

302,903Adjusted net income attributable to Winner Medical Group Inc. (Non-GAAP)3,609,550

4,223,614Earnings per share (GAAP)- Basic 0.14

0.18- Diluted 0.14

0.17Adjusted earnings per share (Non-GAAP)- Basic 0.15

0.19- Diluted 0.15

0.19Weighted average ordinary shares outstanding- Basic24,116,281

22,363,740- Diluted 24,498,551

22,473,167Selling, general and administrative expenses (GAAP)6,056,065

5,323,721Share-based compensation 281,306

302,903Adjusted selling, general and administrative expenses (Non-GAAP)5,774,760

5,020,818 $33.7 million, an increase of 13.2% compared to the same period last year. The increase was mainly attributable to higher average sales prices and increased sales orders from Chinese, North American and South American customers. Export sales to North and South America remained robust, increasing 50.2% year over year, driven by increased orders from American and Brazilian clients who recognized Winner Medical's high quality products and timely delivery capabilities. Orders in Europe remained stable year-over-year as customers in Sweden increased purchases while clients in Greece and Spain postponed orders as a result of the debt crisis. Sales were up 1.0% in China, with steady improvements in November and December. Strong sales of medical dressings and disposables were offset by lower sales of protective gowns and face masks, which were unusually strong in the first quarter of 2010 due to the H1N1 virus outbreak.

Cost of goods sold increased 19.0% to $24.2 million in the first quarter of fiscal 2011, from $20.4 million in the first quarter of fiscal 2010. Cost of goods sold as a percentage of net revenues were 71.9% and 68.3% for the first quarter in fiscal 2011 and 2010, respectively. This increase was mainly attributable to increased raw material prices. To minimize the impacts brought by increased cotton prices, the Company increased its selling price progressively and purchased cotton futures contracts to hedge against the volatility of cotton prices.

Gross profit increased 0.5% to $9.5 million compared to the first quarter of fiscal 2010. Gross margin decreased to 28.1% as compared to 31.7% in the first quarter of fiscal 2010. The decrease in gross margin was mainly attributable to time lag for customers to accept higher selling prices, especially in the months of October and earlier November 2010, as well as lower sales of protective gowns and face masks, which were unusually strong in the first quarter of 2010 due to the H1N1 virus outbreak.

Selling, general and administrative expenses increased by 13.8% to $6.1 million in the first quarter of fiscal 2011, from $5.3 million in the first quarter of fiscal 2010. Adjusted selling, general and administrative expenses (non- GAAP), which exclude share-based compensation expenses, for the first quarter of fiscal 2011 were $5.8 million, versus $5.0 million for the same period of 2010. The increase was primarily due to increased of salary and leasing expenses compared to the same period of last year.

The income tax provision for the first quarter of fiscal 2011 was $0.4 million, compared to $0.6 million for the same period in 2010. This decrease was primarily due to a tax deduction accrued in the reporting quarter for the 150% tax deductible preferential policy applicable to Winner Medical's Research and Development expenses while such an accrual was not made in the same period last fiscal year.

Net income attributable to Winner Medical decreased by 15.1% to $3.3 million, or $0.14 per basic and diluted share, compared to net income of $3.9 million, or $0.18 per basic share and $0.17 per diluted share, for the first quarter of fiscal 2010. The weighted average diluted shares outstanding were 24.1 million, up 7.8% year-over-year. Adjusted net income attributable to Winner Medical Group Inc. (non-GAAP), which excludes non-cash share-based compensation expenses, was $3.6 million for the first quarter of fiscal 2011, a decrease of 14.54% from the same period of 2010. Excluding non-cash share-based compensation expenses, adjusted basic earnings per share (non-GAAP) was $0.15 for the three months ended December 31, 2010, versus $0.19 per share for the comparable period last year, a decrease of 20.75%. The decrease was mainly driven by our customers' delayed acceptance of increased selling prices and lower high-margin protective products sales, which were unusually strong in the first quarter of 2010 due to the H1N1 virus outbreak.

Balance Sheet

Cash and cash equivalents were $10.9 million as at December 31, 2010 compared to $14.8 million as at September 30, 2010. The Company's working capital as of December 31, 2010 was $45.6 million. Total assets were approximately $132.6 million compared to $119.0 million as of September 30, 2010, while total shareholder's equity was $110.8 million and $105.9 million in the respective periods.  

First Quarter 2011 Operational Highlights PurCotton® Business Update:

PurCotton® sales increased 78.08% during the first quarter of 2011 to $4.5 million as a result of steady wholesale sales of jumbo roll to foreign customers and robust growth of our domestic retail business, which distribution channels include chain stores, online sales and wholesales to large customers in China. Revenue generated from PurCotton jumbo rolls and retail sales were $3.6 million and $0.9 million in the first quarter of 2011, respectively.

Gross profit of Winner Medical's PurCotton retail business for the first quarter of fiscal 2011 was $0.48 million. Net loss for the retail segment was $0.5million in the first quarter of 2011 due to start up expenditures, including market research expenses, product development expenses, leasing fees, salary expenses, and expenditures relative to the Company's own B2C website development, expenses which were not incurred in the same period of fiscal 2010. PurCotton retail business losses combined with net income from the PurCotton wholesale business results in a net loss of $0.2 million for all PurCotton® product sales. We consider that the loss from PurCotton retail business was caused by the necessary cost of investment in building our retail business and our PurCotton brand.

As of February 10, 2011, the Company owns and operates 29 PurCotton chain stores in first-tier cities all over China, including four in Beijing, the capital of China, four in Shanghai and 21 stores in Guangdong province where the Company's headquarters is located. Four stores were closed because the Company eliminated those with unsatisfactory performance. During the first quarter of 2011, seven new chain stores were opened, which had limited revenue contribution but did generate start-up expenses for the three months ended December 31, 2010.

In July 2010, the Company opened its first online PurCotton® store at, featuring its entire array of products on, the largest online trading platform in China. In September 2010, the Company also built its own B2C trading website,, which is co-branded through its retail stores. The Company will continue to leverage and expand its online platform to drive incremental sales of PurCotton® retail products.

Fiscal Year 2011 GuidanceWinner Medical reaffirms its total revenues in fiscal year 2011 to be in the range of $138 million to $150 million, representing a 20-30% year-over-year increase.

Conference CallWinner Medical's senior management will host a conference call to discuss its first quarter fiscal year 2011 results and recent business developments.

Date of the conference call:

Thursday, February 10, 2011Time:

08:30 a.m. ESTDial-in Number:

+1-800-659-1966 (US)10-800-130-0399 (South China)10-800-852-1490 (North China)800-96-3844 (Hong Kong) +1-617-614-2711 (International)Pass code:

19641990A telephone replay will be available shortly after the conclusion of the call and will be accessible through February 17, 2010 by calling +1-888-286-8010 (US) or +1-617-801-6888 (International); Pass code: 69835750.

About Winner Medical:Winner Medical is a leading medical disposable products manufacturer in China, with business operations consisting of manufacturing, researching, developing and marketing cotton-based medical dressings and medical disposables, as well as consumer products. The Company has ten wholly-owned operating subsidiaries and three joint ventures, which manufacture tailored medical disposables and dressings, as well as non-woven fabric made from 100% natural cotton.  With a vertically integrated supply chain ranging from spinning fabric to finished goods, the Company provides its customers with a wide range of products, from surgical and wound care to consumer. The Company sells and markets its medical products and 100% natural cotton non-woven jumbo rolls in China and abroad. For nine consecutive years, the Company has been ranked as one of the top medical dressing exporters in China, with the United States, Europe, China and Japan being its most important markets. In addition, the Company distributes finished cotton non-woven consumer products under its own "PurCotton" brand name in China. With more than 20 years of international experience in the medical dressings and disposables field, the Company has a deep market understanding. This provides Winner Medical with a solid foundation, upon which it plans to expand by growing its medical grade 100% cotton retail business. To learn more about Winner Medical, please visit Winner Medical's web site at:

Forward-Looking Statements:This press release contains certain statements that may include "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements regarding Winner Medical and its subsidiary companies' business strategy, plans and objective and statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although Winner Medical believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Winner Medical's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in Winner Medical's periodic reports that are filed with and available from the Securities and Exchange Commission. All forward-looking statements attributable to Winner Medical or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, Winner Medical does not assume a duty to update these forward-looking statements.

Non-GAAP Financial MeasuresTo supplement Winner Medical's consolidated financial results presented in accordance with U.S. GAAP, Winner Medical uses the following non-GAAP measures: adjusted net income attributable to Winner Medical Group Inc., adjusted earnings per share, adjusted income from operations and adjusted selling, general and administrative expenses. These measures represent net income attributable to Winner Medical Group Inc., earnings per share, income from operations and selling, general and administrative expenses, respectively, as adjusted to exclude share-based compensation expense.

Winner Medical believes that, in conjunction with GAAP financial measures, these non-GAAP measures provide meaningful supplemental information regarding its performance and liquidity and both management and investors benefit from referring to these non-GAAP measures in assessing the Company's performance and when planning and forecasting future periods. The calculation of these non-GAAP measures allows the Company to compare its operating results with those of other companies without giving effect to expenses related to share-based compensation, which may vary for different companies for reasons unrelated to the overall operating performance of a company's business.

These non-GAAP measures are not measures of performance under accounting principles generally accepted in the United States (U.S. GAAP). The Company includes them in this press release in order to:

  • improve transparency for investors;

  • assist investors in their assessment of the Company's operating performance;

  • facilitate comparisons to historical performance;

  • ensure that these measures are fully understood in light of how the Company evaluates its operating results; and

  • properly define the metrics used and confirm their calculation.

  • These non-GAAP measures are not meant to be considered in isolation or as a substitute for items appearing on the Company's financial statements prepared in accordance with U.S. GAAP. Rather, the non-GAAP measures should be used as a supplement to U.S. GAAP results to assist the reader in better understanding the operational performance of the Company. The Company recognizes that the usefulness of these non-GAAP measures has certain limitations, including:

  • These non-GAAP measures do not include share-based compensation expense. Because the Company periodically has granted, and expects to continue to grant, options and restricted share awards to its employees, share-based compensation expense is a necessary element of the Company's costs and ability to generate profits and cash flows. Therefore, any measure that excludes share-based compensation expense may have material limitations.

  • The manner in which the Company calculates these non-GAAP measures may differ from that of other companies, which limits their usefulness as comparative measures.

  • Management compensates for these limitations by using these non-GAAP measures as comparative tools, together with U.S. GAAP measurements, to assist in the evaluation of its operating performance. Please refer to the non-GAAP reconciliation tables at the end of this press release for a reconciliation of adjusted net income attributable to Winner Medical Group Inc., adjusted earnings per share, adjusted income from operations and adjusted selling, general and administrative expenses to net income attributable to Winner Medical Group Inc., earnings per share, income from operations and selling, general and administrative expenses, respectively, which are the most directly comparable U.S. GAAP financial measures.

    For more information, please contact:
    Ms. Huixuan Chen (Fiona)
    Investor Relations Manager
    Winner Medical Group Inc.
    Tel:   +86-755-2806-6858
    +86-755-2813-8888 x691
    Mr. Scott Powell
    HC International, Inc.
    Tel:   +1-917-721-9480
    Web:   http://www.hcinternational.netWinner Medical Group Inc.Consolidated Statements of Income and Comprehensive IncomeThree months endedDecember 31
    ,20102009(Unaudited)(Unaudited)US$US$Net sales33,706,318

    29,786,805Cost of sales(24,225,307)

    (20,354,958)Gross profit9,481,011

    9,431,847Other operating income, net336,784

    440,463Exchange difference, net(117,785)

    (24,380)Selling, general and administrative expenses(6,056,065)


     Income from operations3,643,945

    4,524,211Interest income34,540

    17,872Interest expense(45,287)


    SOURCE Winner Medical Group Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Winner Medical Group Inc. to Host First Quarter 2011 Earnings Conference Call on Thursday, February 10, 2011 at 08:30 a.m. EST
    2. Winner Medical Obtains Cotton Processing Certificate from the State Development and Reform Commission
    3. Winner Medical to Participate in Arab Health 2011, International Healthcare Exhibition, in Dubai
    4. Winner Medical Honored with Shenzhen Baoan District Quality Award
    5. Winner Medical and Cotton Inc. Promote PurCotton(R) Brand and Natural(TM) Trademark in Shanghai
    6. Winner Medical Reports Fourth Quarter and Fiscal 2010 Results
    7. 2010 UCB Rheumatoid Arthritis Family Scholarship Winners Announced
    8. MedImmune Announces Winners of the 5th Annual Respiratory, Inflammation and Autoimmunity Research Abstract Competition
    9. Winner Medical Announces Preliminary Fiscal Fourth Quarter 2010 Results
    10. Next-Generation Pharmacist Winner Announced
    11. Winners Announced in 2010 Collegiate Inventors Competition®
    Post Your Comments:
    (Date:10/9/2015)... , Oct. 9, 2015  Impax Laboratories, Inc. ... will release its third quarter 2015 financial results on ... the U.S. financial markets. The Company will host a ... at 8:30 a.m., Eastern Time on November 9, 2015.  ... . --> The financial results and live ...
    (Date:10/9/2015)... Eli Lilly and Company (NYSE: LLY ) ... 50 new jobs to its research and development presence at ... New York . --> ... include a translational immuno-oncology hub and a Lilly "portal," which ... to cutting-edge drug discovery capabilities, including chemistry and lead optimization ...
    (Date:10/9/2015)... Switzerland , October 9, 2015   ... with KUR-111 meets primary efficacy endpoint San Diego, ... Orthopaedics and Chief of Orthopaedic Trauma, NYU Lutheran Medical Center, on ... San Diego, California , by Dr. Tom Lyon ... Medical Center, on 9 th October 2015 at 8:30a.m. PDT. ...
    Breaking Medicine Technology:
    ... (SIX: RO, ROG; OTCQX: RHHBY) announced today that the David ... be using the Roche LightCycler ® 480 System, a ... gene expression and genetic variation, in advanced cancer research. ... 480 System to support several key areas of research it ...
    ... 2011 /PRNewswire/ -- Royal Philips Electronics ... States availability of the Ingenia MRI system, the ... Previously available in Europe, Canada and Japan, the ... Food and Drug Administration. Driven by Philips commitment ...
    Cached Medicine Technology:
    (Date:10/10/2015)... ... October 10, 2015 , ... The Bank of America 500 NASCAR Sprint Cup ... Saturday, October 10th, defending race winner, Kevin Harvick, will battle it out for the ... and all of the stars of the NASCAR Sprint Cup Series. As part ...
    (Date:10/10/2015)... ... October 10, 2015 , ... In the inaugural people’s choice contest, entitled Bold ... Work in Jacksonville, amongst medium-sized companies with 25 – 99 employees. The announcement was ... a celebratory gala on October 1st. , Many of the features of the ...
    (Date:10/9/2015)... ... October 09, 2015 , ... With the FCPX LUT Vibrance pack ... footage. A LUT is a Lookup Table that contains a mathematical formula for modifying ... the table. This pack comes with 60 vibrant CUBE LUT files. , ...
    (Date:10/9/2015)... CA (PRWEB) , ... October 09, 2015 , ... ... now offering a special promotion on Invisalign, the orthodontic system that uses clear, ... The aligners are almost invisible against the teeth, which allow patients to complete ...
    (Date:10/9/2015)... ... 09, 2015 , ... Confidence Plus Insurance has just celebrated ... initiative that involves working with a series of local charities throughout the California ... Insurance is the Gleason Park Electric Violin Ensemble (GPEVE). , GPEVE provides a ...
    Breaking Medicine News(10 mins):
    ... , New Report Highlights Best and Worst State ... Va., Sept. 10 A new report by The Vision Council, ... for children entering school are inconsistent, impeding children,s ability to succeed ... visual processing of information, undetected vision problems can severely impact a ...
    ... largest network of Hispanic health advocates joins President Obama,s efforts to improve ... , WASHINGTON, Sept. 9 "There was a clear ... reform. We need to work together to get the job done and ... our history, it is essential that we do this to support America,s ...
    ... , Statement attributable to: J. James Rohack, M.D. President, ... that Medical Liability Reform is Needed , , ... is unacceptable. The AMA will continue to work for reform that makes ... opportunity this year to achieve meaningful health reform for America,s patients and ...
    ... Sept. 9 In commemoration of the first September 11 National ... Los Angeles will host three 2-hour volunteer orientations for 100+ youth and ... tour of the chapter,s new state of the art Emergency Operation Center, ... recent California wildfires. , , What: ...
    ... MECHANICSBURG, Pa., Sept. 9 Select Medical Holdings ... the launch of its initial public offering of 33,333,333 shares ... is expected to be between $11.00 and $13.00 ... of common shares by Select, and Goldman, Sachs & Co., ...
    ... 9 As the nation awaits President Obama,s address on ... Philanthropic Collaborative (TPC) sent today a letter to the President ... foundations in the field of health. , , ... the social and economic effectiveness of health-related philanthropic activities. ...
    Cached Medicine News:
    CDIs new improved Implant Stabilizer has super-soft elastic bands with lace trim....
    Bras and Breast Support...
    Post-Surgical compression garments...
    ... The Albumin Cobalt Binding (ACB®) Test is ... Modified Albumin (IMA®) by measuring the cobalt ... serum sample. First identified in the early ... comes in contact with ischemic tissue in ...
    Medicine Products: